Chinese Journal of Pharmacovigilance ›› 2025, Vol. 22 ›› Issue (11): 1310-1314.
DOI: 10.19803/j.1672-8629.20240997

Previous Articles     Next Articles

Research Progress in Efficacy of Xinkeshu

MA Yuqin, LIU Xianghuan, ZHANG Shuo, XU Yijia, ZHAO Mingyi*   

  1. School of Life Sciences and Biopharmaceutical Science, Shenyang Pharmaceutical University, Shenyang Liaoning 110016, China
  • Received:2024-12-16 Online:2025-11-15 Published:2025-11-14

Abstract: Objective To explore the multi-target and multi-channel effects of Xinkeshu in the treatment of cardiovascular diseases in order to provide a reference for subsequent development of new cardiovascular drugs. Methods Based on related literature published over the past five years, the pharmacological effects, mechanism of action and clinical applications of Xinkeshu were summarized. The role of Xinkeshu in improving cardiac function and relieving anxiety/ depression was analyzed before its safety was evaluated. Results Studies showed that Xinkeshu had multi-target and multi-channel pharmacological effects. This drug could significantly improve the cardiac function of patients, relieve palpitations, chest tightness and angina pectoris while mitigating anxiety/depression. It was highly safe in that no obvious adverse reactions were found. Conclusion As a Chinese patent medicine that can help promote blood circulation, remove blood stasis, strengthen qi and relieve pain, Xinkeshu is effective and safe in treating palpitation, chest tightness, angina pectoris, hypertension, hyperlipidemia and arrhythmia caused by qi stagnation and blood stasis.

Key words: Xinkeshu, Pharmacological Action, Pharmacological Mechanism, Cardiovascular Disease, Double Heart Disease, Clinical Application

CLC Number: